Unitedhealth Group's average rating is Buy from 18 analysts.
Macroaxis provides recommendation on Unitedhealth Group to complement and cross-verify current
analyst consensus on Unitedhealth Group. Our trade recommendation engine determines the firm's potential to grow exclusively from the perspective of an investor's current risk tolerance and investing horizon.
The successful prediction of Invesco Summit
stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published
stock prices of traded companies, such as Invesco Summit Fund, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at
the intrinsic value of Invesco Summit based on Invesco Summit hews, social hype, general headline patterns, and widely used
predictive technical indicators. We also calculate exposure to Invesco Summit's
market risk, different
technical and
fundamental indicators, relevant financial multiples and ratios, and then
comparing them to Invesco Summit's related companies.
Use Technical Analysis to project Invesco expected Price
Invesco Summit technical mutual fund analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, fund market cycles, or different charting patterns.
A focus of Invesco Summit technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Invesco Summit trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions.
More Info...Sector Allocation
Exchange-Traded Funds use many different techniques to achieve diversification. One of the ways Invesco Summit ETF is managing risk is by picking assets from different sectors and across various asset classes. It helps to ensure that returns are uncorrelated, and risk is spread across the underlying asset classes and industries. Within the same asset class, diversification can be achieved by investing in various investment styles through cross-sector allocation. Below map breaks down Invesco Summit sector allocation.
VolatilityInstrument Allocation
The asset allocation of funds such as Invesco Summit usually varies among a different mix of asset classes. Balanced mutual funds invest not only in bonds, which focus primarily on income, and stocks, which aim for investment growth, but also keep some reserve in cash or even exotic instruments. Below we show the current asset allocation of Invesco Summit Fund
DetailsDetails
The entity reported the last year's revenue of 262.92
B. Total Income to common stockholders was 16.88
B with profit before taxes, overhead, and interest of 67
B.
| 2018 | 2019 | 2020 | 2021 (projected) |
Accounts Payable | 36.6 B | 40.7 B | 44.37 B | 47.87 B | Receivables | 18.25 B | 21.46 B | 25.4 B | 27.41 B |
Deferred Revenue Breakdown
Unitedhealth Deferred Revenue is increasing over the last several years with slightly volatile swings. Deferred Revenue is predicted to flatten to about 1.5
B. Deferred Revenue usually refers to a component of Total Liabilities representing the carrying amount of consideration received or receivable on potential earnings that were not recognized as revenue; including sales; license fees; and royalties; but excluding interest income. Unitedhealth Deferred Revenue is most likely to increase significantly in the upcoming years. The last year's value of Deferred Revenue was reported at 1.77 Billion
| 2011 | 1.23 Billion |
| 2012 | 1.5 Billion |
| 2013 | 1.6 Billion |
| 2014 | 1.97 Billion |
| 2015 | 2.14 Billion |
| 2016 | 1.97 Billion |
| 2020 | 1.77 Billion |
| 2021 | 1.48 Billion |
Will price continue to rise in August 2021?
Current expected short fall is at -0.81. Unitedhealth Group has low volatility with Treynor Ratio of 0.16, Maximum Drawdown of 6.01 and kurtosis of 2.15. However, we advice all investors to further analyze Unitedhealth Group to make certain all market information is desiminated and is consistent with the current expectations about Unitedhealth upside potential. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Unitedhealth's stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Unitedhealth's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.
Our Final Take On Unitedhealth
While some other entities within the healthcare plans industry are still a little expensive, even after the recent corrections, Unitedhealth may offer a potential longer-term growth to stockholders. While some stockholders may not share our view, we believe it may be a good time to increase your existing holdings in Unitedhealth. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to Unitedhealth.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
Rifka Kats is a Member of Macroaxis Editorial Board. Rifka writes about retail product and service companies from the perspective of a regular consumer and sophisticated investor at the same time. She is passionate about corporate ethics and equality in the workforce.
View Profile This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Rifka Kats do not own shares of Invesco Summit Fund. Please refer to our
Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to
editors@macroaxis.com
